A mixture of isomers of: 1,1'-[(3,5(or 2,4 or 4,6 or 2,6)-dihydroxy-o(or m or p)-phenylene)bis(azo-meta-phenyleneazo{1-[3-(dimethylamino)propyl]-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl})]dipyridinium-dichloride-dihydrochloride; 1-(1-[3-(dimethylamino)propyl]-5-{3-[x-(4-{1-[3-(dimethylamino)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo}phenylazo)-2,4(or 2,6 or 3,5 or 4,6)-dihydroxyphenylazo]phenylazo}-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium-dichloride-dihydrochloride (where x is variable)

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Type of information:

experimental study

Adequacy of study:

key study

Study period:

1989-03-09 to 1989-04-14

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1989

Report date:

1989

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Version / remarks:

1983

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)

Version / remarks:

1984

GLP compliance:

yes

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

A mixture of isomers of: 1,1'-[(3,5(or 2,4 or 4,6 or 2,6)-dihydroxy-o(or m or p)-phenylene)bis(azo-meta-phenyleneazo{1-[3-(dimethylamino)propyl]-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl})]dipyridinium-dichloride-dihydrochloride; 1-(1-[3-(dimethylamino)propyl]-5-{3-[x-(4-{1-[3-(dimethylamino)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo}phenylazo)-2,4(or 2,6 or 3,5 or 4,6)-dihydroxyphenylazo]phenylazo}-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium-dichloride-dihydrochloride (where x is variable)

EC Number:

404-540-1

EC Name:

A mixture of isomers of: 1,1'-[(3,5(or 2,4 or 4,6 or 2,6)-dihydroxy-o(or m or p)-phenylene)bis(azo-meta-phenyleneazo{1-[3-(dimethylamino)propyl]-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl})]dipyridinium-dichloride-dihydrochloride; 1-(1-[3-(dimethylamino)propyl]-5-{3-[x-(4-{1-[3-(dimethylamino)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo}phenylazo)-2,4(or 2,6 or 3,5 or 4,6)-dihydroxyphenylazo]phenylazo}-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium-dichloride-dihydrochloride (where x is variable)

Cas Number:

159405-95-5

Molecular formula:

C50H56Cl4N14O6

IUPAC Name:

1'-[3-(dimethylamino)propyl]-5'-(2-{3-[2-(4-{2-[3-(2-{1'-[3-(dimethylamino)propyl]-6'-hydroxy-4'-methyl-2'-oxo-1',2'-dihydro-1λ⁵-[1,3'-bipyridin]-1-ylium-5'-yl}diazen-1-yl)phenyl]diazen-1-yl}-2,6-dihydroxyphenyl)diazen-1-yl]phenyl}diazen-1-yl)-6'-hydroxy-4'-methyl-2'-oxo-1',2'-dihydro-1λ⁵-[1,3'-bipyridin]-1-ylium 1'-[3-(dimethylamino)propyl]-5'-(2-{4-[2-(4-{2-[4-(2-{1'-[3-(dimethylamino)propyl]-6'-hydroxy-4'-methyl-2'-oxo-1',2'-dihydro-1λ⁵-[1,3'-bipyridin]-1-ylium-5'-yl}diazen-1-yl)phenyl]diazen-1-yl}-2,6-dihydroxyphenyl)diazen-1-yl]phenyl}diazen-1-yl)-6'-hydroxy-4'-methyl-2'-oxo-1',2'-dihydro-1λ⁵-[1,3'-bipyridin]-1-ylium tetrahydrochloride tetrachloride

Test material form:

solid

Method

Target gene:

The objective of this study was to evaluate the test substance for its ability to induce reverse mutations in a gene of histidine-requiring Salmonella Iyphimurium bacterial strains to produce histidine-independent strains of these micro-organisms.

Species / strain

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Additional strain / cell type characteristics:

other: rfa: deep rough (defective lipopolysaccharide cellcoat); gal: mutation in the galactose metabolism; chi: mutation in nitrate reductase; bio: defective biotin synthesis; uvrB: loss of the excision repair system (deletion of the ultravioletrepair B gene)

Metabolic activation:

with and without

Metabolic activation system:

Aroclor induced rat liver S9

Test concentrations with justification for top dose:

Concentration range in the main test (with metabolic activation): 3.3, 10, 33.3, 100, 333 µg/plate
Concentration range in the main test (without metabolic activation): 1, 3.3, 10, 33.3, 100 µg/plate

Vehicle / solvent:

Solvent: deionised (Milli-Q) water

Controls

Controls 1

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

9-aminoacridine

sodium azide

methylmethanesulfonate

other: daunomycine

Remarks:

without S9-mix

Controls 2

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

other: 2-aminoanthracene

Remarks:

with S9-mix

Details on test system and experimental conditions:

METHOD OF APPLICATION: in agar (direct plate incorporation)

DURATION
- Preincubation period: no
- Exposure duration: 48 h
- Expression time (cells in growth medium): 48 h
- Selection time (if incubation with a selection agent): 48 h
- Fixation time (start of exposure up to fixation or harvest of cells): 48 h

SELECTION AGENT (mutation assays): histidine

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
The survival of the TA100 culture is determined by comparing the number of colonies on the plates containing the test substance with those on the solvent control plate.
In the absence of S9-mix the survival of strain TA100 is severely reduced at test substance concentrations from 333 µg/plate upwards. Both in the absence and presence of S9-mix the survival is eliminated from 1000 µg/plate upwards. Based on these data, the test substance was tested up to a concentration of 100 µg/plate in the absence of S9-mix and up to 333 µg/plate in the presence of S9-mix.

Evaluation criteria:

A test substance was considered negative (not mutagenic) in the Ames test if:
a) The total number of revertants in any tester strain at any concentration was not greater than two times the solvent control value, with or without metabolic activation.
b) The negative response should be reproducible in at least one independently repeated experiment.

A test substance was considered positive (mutagenic)in the Ames test if:
a) It induced at least a 2-fold, dose related increase in the number of revertants with respect to the number induced by the solvent control in any of the tester strains, either with or without metabolic activation. However, any mean plate count of less than 20 was considered to be not significant. If the test substance showed in the first test only a positive response at one or two concentrations, the assay was repeated with doses just below and exceeding those showing positive effects in the first test.
b) The positive response should be reproducible in at least one independently repeated experiment.

Statistics:

see "data evaluation criteria"

Results and discussion

Test results

Test results 1

Species / strain:

S. typhimurium TA 102

Metabolic activation:

with and without

Genotoxicity:

other: not tested; only 4 strains.

Cytotoxicity / choice of top concentrations:

other: not tested; only 4 strains.

Vehicle controls validity:

not applicable

Positive controls validity:

not applicable

Test results 2

Species / strain:

S. typhimurium TA 100

Metabolic activation:

without

Genotoxicity:

not determined

Remarks:

range-finding test

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

≥ 333 µg/plate

Vehicle controls validity:

valid

Positive controls validity:

not applicable

Test results 3

Species / strain:

S. typhimurium TA 100

Metabolic activation:

with

Genotoxicity:

not determined

Remarks:

range-finding test

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

≥ 1000 µg/plate

Vehicle controls validity:

not specified

Positive controls validity:

not applicable

Test results 4

Species / strain:

S. typhimurium TA 1535

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Positive controls validity:

valid

Test results 5

Species / strain:

S. typhimurium TA 1537

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Positive controls validity:

valid

Test results 6

Species / strain:

S. typhimurium TA 98

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Positive controls validity:

valid

Test results 7

Species / strain:

S. typhimurium TA 100

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Positive controls validity:

valid

Additional information on results:

TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no data
- Effects of osmolality: no data
- Evaporation from medium: no data
- Water solubility: no effects
- Precipitation: no

RANGE-FINDING/SCREENING STUDIES:
Selection of an adequate range of doses was based on a preliminary toxicity test with strain TA100, both with and without S9-mix. Nine concentrations have been tested in duplicate for toxicity. The highest concentration of test article used in the subsequent mutagenesis assay was that which gave a reduced survival on the non-selective plates. If no toxicity was observed, the highest dose level used in the mutagenesis assay was 5 mg/plate unless the test article exhibited limited solubility or was not uniformly dispersible in the solvent of choice.

COMPARISON WITH HISTORICAL CONTROL DATA:
The negative and strain-specific positive control values fell within the laboratory's background historical ranges indicating that the test conditions were optimal and that the metabolic activation system functioned properly.

Any other information on results incl. tables

Preliminary toxicity determination in TA 100

conc. µg/plate	viable counts/plate (duplicate plates)
	without S9 mix		with S9-mix
control	420	465	490	500
1.0	317	385	357	365
3.3	418	350	366	348
10.0	398	377	319	345
33.3	358	318	413	372
100	298	199	318	353
333	87	98	218	225
1000	0	0	0	0
3330	0	0	0	0
5000	0	0	0	0

Experiment 1

conc. µg/plate	without S9-mix
	TA1535	TA1537	TA98	TA100
control	13±2	18±4	32±2	120±11
1.0	10±4	20±6	28±4	121±18
3.3	10±3	17±6	27±2	102±12
10.0	6±4	15±2	26±7	112±15
33.3	11±3	22±4	35±6	121±3
100	8±1	20±6	22±4	121±15
positive control	200±13	477±72	503±130	576±267
	with S9-mix
control	8±2	11±4	26±4	114±13
3.3	6±1	15±3	22±1	124±7
10.0	7±2	15±4	23±2	11±10
33.3	8±5	10±1	26±9	123±7
100	10±2	16±6	26±3	125±3
333.3	10±3	13±3	30±7	112±3
positive control	189±20	414±14	599±48	730±84

Experiment 2

conc. µg/plate	without S9-mix
	TA1535	TA1537	TA98	TA100
control	8±5	13±4	28±6	105±20
1.0	12±3	15±3	31±11	109±11
3.3	12±5	15±1	36±10	114±12
10.0	9±3	15±4	30±10	110±5
33.3	10±7	16±4	22±2	108±7
100	11±2	14±1	28±4	126±8
positive control	201±6	477±72	1103±70	586±54
	with S9-mix
control	9±2	7±1	34±2	122±2
3.3	15±1	13±2	38±6	135±11
10.0	9±1	8±5	26±4	126±9
33.3	14±1	8±3	35±8	125±6
100	13±3	11±1	37±5	132±3
333.3	8±4	10±2	44±3	139±12
positive control	161±34	588±76	705±29	815±7

Applicant's summary and conclusion

Conclusions:

Negative: test substance can be considered as not mutagenic under test conditions of the Ames Salmonella/microsome assay.

Executive summary:

Aim of the study was to evaluate the test substance for its ability to induce reverse mutations in a gene of histidine-requiring Salmonella typhimurium bacterial strains to produce histidine-independent strains of these micro-organisms. The study followed OECD guideline 471.

The substance was tested in the Ames Salmonella/microsome plate test up to 100 µg/plate in the absence of S9-mix and up to 333 µg/plate in the presence of S9-mix (dose range as result of a preliminary range finding study).

All bacterial strains showed negative responses over the entire dose range of the test substance, i.e. no dose related, two-fold, increase in the number of revertants in two independently repeated experiments. The negative and strain-specific positive control values fell within our laboratory background historical ranges indicating that the test conditions were optimal and that the metabolic activation system functioned properly.

Based on these findings, the test substance did not induce a dose-related increase in the number of revertant (His+) colonies in each of the four tester strains (TA1535; TA1537; TA98 and TA100). These results were confirmed in an independently repeated experiment. The test substance can, thus, be considered as not mutagenic under test conditions.